Navigation Links
The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics
Date:9/27/2013

DUBLIN, September 27, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/hg72tl/metabolomics) have announced the addition of the "The Global Metabolomics Market 2013 Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

This report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as: (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include:

- Agilent Technologies
- Bruker Corporation
- Metabolomic Technologies
- Metabolon
- Chenomx
- Bio-Rad Laboratories
- Waters Corporation
- Human Metabolome Technologies
- Nextgen Metabolomics
- Biocrates Life Sciences Ag
- Stemina Biomarker
- Phenomenome
- Metanomics Gmbh
- Accelrys
- Eisai Co. Ltd.
- Shimadzu Corporation
- Sidmap, Llc
- Astrazeneca Plc
- Ab Sciex
- Metabolomx
- Research Institute Of Chromatography (Ric)

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Metabolomics -Technology Landscape Analysis

4. Metabolomics - Market Landscape Analysis

5. Metabolomics - Technology Investment Potential

6. Metabolomics - Geographical Analysis

7. Competitive Landscape Analysis

8. Patent Analysis

9. Technology Analysis (Using Multi Criteria Decision Making) & Road Mapping

10. Analyst Insights & Recommendations

11. Company Profiles

For more information visit  http://www.researchandmarkets.com/research/hg72tl/metabolomics
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Rising Concerns Over Food Safety Drives Demand for Agricultural and Environmental Diagnostics, According to New Report by Global Industry Analysts, Inc.
2. Global Medical Experts to Discuss Knowledge Translation for Integration of Complementary Therapies in Cancer Treatment at Vancouver, BC Conference
3. Global Salicylic Acid Market is Expected to Reach USD 521.2 million in 2019: Transparency Market Research
4. Global Demand for Pharmaceutical Regulatory Specialists Escalating Rapidly
5. ACRES Announces Strategic Alliance with Atlantis Global Research Institute
6. Sandia Biotech, Inc. and Sigma-Aldrich Enter into Global Distribution and Marketing Agreement
7. Managing Cultural Variability in PRO Measurement in Global Clinical Research, New Life Science Webinar Hosted by Xtalks
8. Serial Entrepreneur, Rudy Mazzocchi, Receives Global Business Recognition Award as the 2013 Entrepreneur of the Year
9. First Aid Global Warns People to Prepare for Mobility Restrictions during Federal Emergencies as per Article Written by Denise Brehm, Civil and Environmental Engineer
10. Nerve Repair and Regeneration Market - Global Trend and Forecast to 2018
11. Technology Developments Drive Growth in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, According to New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
Breaking Biology News(10 mins):